Weichao Ma

409 citations
19 papers · 279 indexed · h-index 10
Topics
Pituitary Gland Disorders and Treatments (8 papers)Adrenal and Paraganglionic Tumors (5 papers)Glioma Diagnosis and Treatment (4 papers)

In The Last Decade

Weichao Ma

19 papers receiving 277 citations

Peers

Weichao Ma
Comparison fields: 5 of 49
  • Endocrinology, Diabetes and Metabolism 112
  • Molecular Biology 110
  • Surgery 89
  • Cancer Research 74
  • Epidemiology 72
Replace Yukiko Odake with:
Yukiko Odake Japan
Araceli García‐Martínez Spain
Jacek Kunicki Poland
Paul D. Bates United States
Nuria Valdés Spain
Christina Stache Germany
Zhi Peng Su China
Nikolaos Settas United States
Craig E Stiles United Kingdom
Lucieli Ceolin Brazil
Weichao Ma relative to Yukiko Odake Japan Yukiko Odake's profile →
Citations per field
00.5×2.8×
Yukiko Odake · 1×
Citations per year

Countries citing papers authored by Weichao Ma

Since Specialization
Citations

This map shows the geographic impact of Weichao Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weichao Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weichao Ma more than expected).

Fields of papers citing papers by Weichao Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weichao Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weichao Ma. The network helps show where Weichao Ma may publish in the future.

Co-authorship network of co-authors of Weichao Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Weichao Ma. A scholar is included among the top collaborators of Weichao Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weichao Ma. Weichao Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 1
2 19
3 6
4 9
5 8
6 11
7 18
8 3
9 74
10 8
11 24
12 16
13 18
14 14
15 10
16 27
17
[Isolation and preliminary identification of stem-like cells in pituitary adenoma].
1
18 7
19 5

About Weichao Ma

Weichao Ma is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Biological Psychiatry, having authored 19 papers that have together received 279 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (8 papers), Adrenal and Paraganglionic Tumors (5 papers) and Glioma Diagnosis and Treatment (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (112 citations), Genetics (53 citations) and Cancer Research (74 citations). Weichao Ma has collaborated with scholars based in China, Russia and United Kingdom. Frequent co-authors include Peizhi Zhou, Shu Jiang, Liang Lv, Senlin Yin, Xiujie Wang, Yu Hu, Lihua Dong, Li Wang, Zhen Sun and Jie Zhang. Their work appears in journals such as British Journal of Cancer, Medicine and Osteoporosis International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026